证券记录 · 已归档季度
GSK
GSK plc · Healthcare · Drug Manufacturers - General
18被追踪持有人
-1Δ持有人
242.57M持有股份
$10.47B报告持仓市值
+1新建仓位
−3清仓
动量输入（同类管理人）：
持有人广度 -5.3% ·
股份流向 +2.4% ·
净新建仓位 -11.1%
· 公式
集中增持：持股数量上升，持有人数量减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 163.18K | $7.64M | n/a | −1 |
| Q2 2026 | 115 | +1 | 291.71M | $15.16B | +8 | −8 |
| Q1 2026 | 116 | 0 | 315.42M | $17.28B | +8 | −8 |
| Q4 2025 | 115 | +4 | 328.16M | $15.98B | +4 | n/a |
| Q3 2025 | 18 | -1 | 242.57M | $10.47B | +1 | −3 |
| Q2 2025 | 17 | +1 | 220.73M | $8.48B | +2 | −1 |
| Q1 2025 | 14 | -1 | 157.56M | $6.11B | n/a | −1 |
| Q4 2024 | 15 | -1 | 135.53M | $4.59B | n/a | −1 |
| Q3 2024 | 15 | +3 | 120.78M | $4.99B | +3 | n/a |
| Q2 2024 | 12 | n/a | 118.47M | $4.56B | n/a | n/a |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Dodge & Cox ✦ | 78.40M | -0.5% | $3.38B | 1.8% | ▼ Trim | 6 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 66.14M | +8.4% | $2.85B | 0.1% | ▲ Add | 2 | SEC ↗ ×4 |
| 3 | Fisher Asset Management ✦ | 32.23M | +2.8% | $1.39B | 0.5% | ▲ Add | 6 | SEC ↗ |
| 4 | PRIMECAP Management ✦ | 25.77M | -7.1% | $1.11B | 0.9% | ▼ Trim | 6 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 7.95M | -1.2% | $343.21M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 6 | State Street Global Advisors ✦ (被动) | 6.62M | -1.4% | $288.71M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 7 | Goldman Sachs Group ✦ | 6.52M | n/a | $281.36M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 8 | Morgan Stanley ✦ | 4.95M | n/a | $213.61M | 0.0% | n/c | 1 | SEC ↗ ×9 |
| 9 | JPMorgan Chase ✦ | 4.70M | n/a | $202.85M | 0.0% | n/c | 1 | SEC ↗ ×20 |
| 10 | Wellington Management ✦ | 3.42M | +135.1% | $147.62M | 0.0% | ▲ Add | 6 | SEC ↗ ×5 |
| 11 | Renaissance Technologies ✦ | 1.99M | -11.7% | $85.80M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 12 | BlackRock ✦ (被动) | 1.97M | +23.1% | $85.21M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 13 | Bridgewater Associates ✦ | 1.40M | +4.3% | $60.50M | 0.2% | ▲ Add | 6 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 203.61K | +282.1% | $8.79M | 0.0% | ▲ Add | 6 | SEC ↗ ×4 |
| 15 | Two Sigma Investments ✦ | 89.50K | 0.0% | $3.86M | 0.0% | Held | 5 | SEC ↗ |
| 16 | Tweedy, Browne ✦ | 82.24K | -5.3% | $3.55M | 0.3% | ▼ Trim | 6 | SEC ↗ |
| 17 | Millennium Management ✦ | 64.99K | -17.1% | $2.80M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 18 | Marshall Wace ✦ | 63.89K | 新增 | $2.76M | 0.0% | New | 1 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Marshall Wace | $2.76M | 0.0% |
已清仓
| Citadel Advisors | $4.67M | 曾为 0.0% |
| Norges Bank | $2.11M | 曾为 0.0% |
| Adage Capital Partners | $344,333 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 1,022 持有人, 373.63M 股份, $18.86B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据